Multi-center prospective observational study for analysis of efficacy and safety of SARS-CoV-2 vaccine in kidney transplant recipients

Multi-center prospective observational study for analysis of efficacy and safety of SARS-CoV-2 vaccine in kidney transplant recipients - SVKTR PROS study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047360

Enrollment

400

Registered

2022-04-01

Start date

2021-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease (Post Kidney Transplantation)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1: Adult patient at the time of consent acquisition. 2: Patients who have received sufficient explanation in participating in this study, and who have obtained the patient's free will to consent to the document after sufficient understanding.

Exclusion criteria

Exclusion criteria: 1: Patients under 20 years. 2: Patients with SARS-CoV-2 infection prior to vaccination. 3: Patients vaccinated with other vaccines within 2 weeks before and after SARS-CoV-2 vaccination. 4: Patients judged by the principal investigator to be inappropriate as subjects

Design outcomes

Primary

Measure	Time frame
Antibody positive rate among kidney transplant recipients with antibody negatives before vaccination. (After 4 weeks after vaccination)	—

Countries

Japan

Contacts

Public ContactHajime Sasaki

Sapporo City General Hospital Department of Kidney Transplant Surgery

hajimes1207@hotmail.com011-726-2211

Outcome results